Estrogen response element binding induces alterations in estrogen-α conformation as revealed by susceptibility to partial proteolysis

Journal of Molecular Endocrinology

Volumn 27, Issue 3, 2001, Pages 275-292

  Ramsey, T L ^a   Klinge, C M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PROTEIN PS2; REGULATOR PROTEIN;

ANIMAL CELL; ARTICLE; CHINESE HAMSTER; CLINICAL OBSERVATION; CONFORMATIONAL TRANSITION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA PROTEIN COMPLEX; DRUG RECEPTOR BINDING; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HYPOTHESIS; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; RECEPTOR OCCUPANCY; REPORTER GENE; TANDEM REPEAT; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CHO CELLS; CRICETINAE; DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENES, REPORTER; HUMANS; LUCIFERASES; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; PROTEINS; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; TAMOXIFEN; TANDEM REPEAT SEQUENCES; TRANS-ACTIVATION (GENETICS); TRYPSIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0035202469     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0270275     Document Type: Article

References (57)

1. Estrogen receptor alpha requires no accessory factors for high-affinity binding to a consensus response element
2. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA
3. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand
4. Stability of the ligand of estrogen response element-bound estrogen receptor depends on flanking sequences and cellular factors
5. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
6. Human estrogen receptor forms multiple protein-DNA complexes
7. Molecular basis of agonism and antagonism in the oestrogen receptor
8. Effect of ligand binding and DNA binding on the structure of the mouse oestrogen receptor
9. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain
10. DNA allosterically modulates the steroid binding domain of the estrogen receptor
11. Structural characterization of the trypsinized estrogen receptor
12. Probing conformational changes in the estrogen receptor: Evidence for a partially unfolded intermediate facilitating ligand binding and release
13. Proteins associated with untransformed estrogen receptor in vitro
14. Different DNA elements can modulate the conformation of thyroid hormone receptor heterodimer and its transcriptional activity
15. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II)
16. A short N-terminal motif defines a novel transcriptional synergy regulatory surface in steroid receptors
17. Interaction of androgen receptors with androgen response element in intact cells. Roles of amino- and carboxyl-terminal regions and the ligand
18. Editorial: A new actor in the estrogen receptor drama-enter ERβ
19. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF)
20. Estrogen receptor interaction with co-activators and co-repressors
21. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro
22. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro
23. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor when the receptor binds estrogen response element DNA
24. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro
25. Hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro
26. COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression
27. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements
28. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements
29. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRα1
30. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α
31. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: Correlations with biological character and distinct differences among SRC coactivator family members
32. Ligand-dependent, transcriptionally productive association of the amino- and carboxy-terminal regions of a steroid hormone nuclear receptor
33. Regulation of retinoid signaling receptor polarity and allosteric control of ligand binding
34. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: Correlations with DNA and coregulator interactions and receptor conformational changes
35. The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18
36. Allosteric effects of DNA on transcriptional regulators
37. Nuclear receptor coregulators: Cellular and molecular biology
38. The nuclear receptor superfamily: The second decade
39. 5-Flanking sequences in thyroid hormone response element half-sites determine the requirement of retinoid X receptor for receptor-mediated gene expression
40. Thyroid hormone response element architecture affects corepressor release from thyroid hormone receptor dimers
41. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
42. Hydroxylapatite 'batch' assay for estrogen receptor: Increased sensitivity over present receptor assays
43. Properties of a high-affinity DNA binding site for estrogen receptor
44. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
45. Transcriptional activators differ in their responses to over-expression of TATA-box-binding protein
46. Effects of multiple estrogen responsive elements, their spacing and location on estrogen response of reporter genes
47. Glucocorticoid steroid receptor dimerization investigated by analysis of receptor binding to glucocorticoid responsive elements using a monomer-dimer equilibrium mode
48. Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis
49. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
50. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element
51. A mathematical approach to predict the affinity of estrogen receptors α and β binding to estrogen response elements, half-sites, and direct repeats
52. Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements
53. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
54. Biochemistry
55. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function
56. Estrogen response elements function as allosteric modulators of estrogen receptor conformation
57. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability